167 related articles for article (PubMed ID: 32222663)
1. Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.
Fu K; Bai Z; Chen L; Ye W; Wang M; Hu J; Liu C; Zhou W
Eur J Med Chem; 2020 May; 193():112221. PubMed ID: 32222663
[TBL] [Abstract][Full Text] [Related]
2. Role of heparanase in tumor progression: Molecular aspects and therapeutic options.
Masola V; Zaza G; Gambaro G; Franchi M; Onisto M
Semin Cancer Biol; 2020 May; 62():86-98. PubMed ID: 31348993
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
4. λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration.
Groult H; Cousin R; Chot-Plassot C; Maura M; Bridiau N; Piot JM; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30818840
[TBL] [Abstract][Full Text] [Related]
5. Heparanase expression and function during early pregnancy in mice.
D'Souza SS; Daikoku T; Farach-Carson MC; Carson DD
Biol Reprod; 2007 Sep; 77(3):433-41. PubMed ID: 17507691
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of small-molecule heparanase inhibitors.
Zhang Y; Cui L
Bioorg Med Chem; 2023 Jul; 90():117335. PubMed ID: 37257254
[TBL] [Abstract][Full Text] [Related]
8. Chemical toolbox to interrogate Heparanase-1 activity.
Rabinowitz ZM; Somers J; Wang Z; Cui L
Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of heparanase in cancer therapy: Current trends and future direction.
Yang Y; Yuan F; Zhou H; Quan J; Liu C; Wang Y; Xiao F; Liu Q; Liu J; Zhang Y; Yu X
J Cell Physiol; 2023 May; 238(5):896-917. PubMed ID: 36924082
[TBL] [Abstract][Full Text] [Related]
10. PI-88 and Related Heparan Sulfate Mimetics.
Chhabra M; Ferro V
Adv Exp Med Biol; 2020; 1221():473-491. PubMed ID: 32274723
[TBL] [Abstract][Full Text] [Related]
11. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
Wu L; Davies GJ
Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
[TBL] [Abstract][Full Text] [Related]
12. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
13. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
14. Heparanase Inhibitors in Cancer Progression: Recent Advances.
Kaur R; Deb PK; Diwan V; Saini B
Curr Pharm Des; 2021; 27(1):43-68. PubMed ID: 33185156
[TBL] [Abstract][Full Text] [Related]
15. Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Rondanin R; Fochi S; Baruchello R; Bernardi T; Oliva P; Semeraro F; Simoni D; Giannini G
Bioorg Med Chem Lett; 2017 Sep; 27(18):4421-4425. PubMed ID: 28811133
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and
Spyrou A; Kundu S; Haseeb L; Yu D; Olofsson T; Dredge K; Hammond E; Barash U; Vlodavsky I; Forsberg-Nilsson K
Mol Cancer Ther; 2017 Aug; 16(8):1705-1716. PubMed ID: 28716813
[TBL] [Abstract][Full Text] [Related]
18. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
19. 4-O-Substituted Glucuronic Cyclophellitols are Selective Mechanism-Based Heparanase Inhibitors.
Borlandelli V; Armstrong Z; Nin-Hill A; Codée JDC; Raich L; Artola M; Rovira C; Davies GJ; Overkleeft HS
ChemMedChem; 2023 Feb; 18(4):e202200580. PubMed ID: 36533564
[TBL] [Abstract][Full Text] [Related]
20. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
